Replies to post #221229 on Biotech Values

[Whalatane]

VXRT. thx Dew
Kiwi

[DewDiligence]

VXRT 3Q18 results—cash=$17.9M ($6.0M quarterly burn):

https://finance.yahoo.com/news/vaxart-announces-third-quarter-2018-133000036.html

I’m astonished that VXRT did not raise capital following the release of phase-2 data on 10/4/18 (#msg-143987274).